|
OMIM |
Link |
Information gain |
01 |
|
twinning, dizygotic
|
[NCBI]
|
0.00320685
|
|
|
SLI2
|
[NCBI]
|
0.00199521
|
|
|
SLI1
|
[NCBI]
|
0.00199521
|
|
|
HFM
|
[NCBI]
|
0.00183192
|
|
|
iris pattern
|
[NCBI]
|
0.000995284
|
|
|
exstrophy of bladder
|
[NCBI]
|
0.000995284
|
|
|
clubbing of digits
|
[NCBI]
|
0.000995284
|
|
|
anencephaly
|
[NCBI]
|
0.000971013
|
|
|
intelligence quantitative trait locus 1
|
[NCBI]
|
0.000731111
|
|
|
symphalangism, distal
|
[NCBI]
|
0.000731111
|
|
|
mutagen sensitivity
|
[NCBI]
|
0.00063205
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.00063205
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.000568085
|
|
|
DYX6
|
[NCBI]
|
0.000568085
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000568085
|
|
|
achalasia, familial esophageal
|
[NCBI]
|
0.00045232
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.00045232
|
|
|
acetabular dysplasia
|
[NCBI]
|
0.00045232
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
0.00042594
|
|
|
neuroticism
|
[NCBI]
|
0.00042594
|
|
|
short rib-polydactyly syndrome, type iv
|
[NCBI]
|
0.000403007
|
|
|
AFP
|
[NCBI]
|
0.000387271
|
|
|
BULN1
|
[NCBI]
|
0.000382751
|
|
|
WM1
|
[NCBI]
|
0.000382751
|
|
|
autism
|
[NCBI]
|
0.000366197
|
|
|
MCKD1
|
[NCBI]
|
0.000333344
|
|
|
MYP2
|
[NCBI]
|
0.000319658
|
|
|
PAND1
|
[NCBI]
|
0.000307026
|
|
|
longevity
|
[NCBI]
|
0.00023062
|
|
|
atrioventricular conduction time
|
[NCBI]
|
0.000203604
|
|
|
PCD
|
[NCBI]
|
0.00018681
|
|
|
TFPI2
|
[NCBI]
|
0.000165301
|
|
|
MAFD2
|
[NCBI]
|
0.000162091
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
0.000159084
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000157673
|
|
|
RA
|
[NCBI]
|
0.000153985
|
|
|
PCOS1
|
[NCBI]
|
0.000153406
|
|
|
TD1
|
[NCBI]
|
0.000150061
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.000145296
|
|
|
toes, relative length of first and second
|
[NCBI]
|
0.000129456
|
|
|
sc(1) trait of saliva
|
[NCBI]
|
0.000129456
|
|
|
twinning due to superfetation
|
[NCBI]
|
0.000129456
|
|
|
spastic paraplegia, optic atrophy, microcephaly, and xy sex reversal
|
[NCBI]
|
0.000129456
|
|
|
palmomental reflex
|
[NCBI]
|
0.000129456
|
|
|
dysphasia, familial developmental
|
[NCBI]
|
0.000129456
|
|
|
hydrocephalus with associated malformations
|
[NCBI]
|
0.000129456
|
|
|
proteolytic capacity of plasma
|
[NCBI]
|
0.000129456
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
0.000105391
|
|
|
pyridoxamine 5-prime-phosphate oxidase deficiency
|
[NCBI]
|
0.000101713
|
|
|
electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon
|
[NCBI]
|
0.000101713
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
0.000101713
|
|
|
ankyloblepharon filiforme adnatum and cleft palate
|
[NCBI]
|
0.000101713
|
|
|
alkaline phosphatase, blood group-associated
|
[NCBI]
|
0.000101713
|
|
|
mental retardation syndrome, mietens-weber type
|
[NCBI]
|
0.000101713
|
|
|
bowing of legs, anterior, with dwarfism
|
[NCBI]
|
0.000101713
|
|
|
RSTS
|
[NCBI]
|
0.000100194
|
|
|
SLE
|
[NCBI]
|
9.43218e-05
|
|
|
obesity
|
[NCBI]
|
9.31348e-05
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
9.12613e-05
|
|
|
androstenone, ability to smell
|
[NCBI]
|
9.12613e-05
|
|
|
mydriatic response to pharmacologic agents
|
[NCBI]
|
9.12613e-05
|
|
|
ALPP
|
[NCBI]
|
8.72835e-05
|
|
|
CPI
|
[NCBI]
|
8.51046e-05
|
|
|
EEG
|
[NCBI]
|
8.44848e-05
|
|
|
hair whorl
|
[NCBI]
|
8.44848e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
7.94538e-05
|
|
|
EHBA
|
[NCBI]
|
7.54509e-05
|
|
|
oeis complex
|
[NCBI]
|
7.54509e-05
|
|
|
gastroschisis
|
[NCBI]
|
7.54509e-05
|
|
|
twinning, monozygotic
|
[NCBI]
|
7.21273e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
7.21273e-05
|
|
|
BPP
|
[NCBI]
|
6.92866e-05
|
|
|
BWS
|
[NCBI]
|
6.61075e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
6.46074e-05
|
|
|
GBD1
|
[NCBI]
|
6.46074e-05
|
|
|
myeloma, multiple
|
[NCBI]
|
6.26318e-05
|
|
|
MS
|
[NCBI]
|
6.18222e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
6.08391e-05
|
|
|
SHEP1
|
[NCBI]
|
5.91988e-05
|
|
|
BMND1
|
[NCBI]
|
5.91988e-05
|
|
|
MCPH1
|
[NCBI]
|
5.62863e-05
|
|
|
CFTD
|
[NCBI]
|
5.62863e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
5.49808e-05
|
|
|
coumarin resistance
|
[NCBI]
|
5.49808e-05
|
|
|
DYX2
|
[NCBI]
|
5.37591e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
5.37591e-05
|
|
|
SPCH1
|
[NCBI]
|
5.37591e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
5.15286e-05
|
|
|
HSR
|
[NCBI]
|
5.14464e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
5.05049e-05
|
|
|
polycythemia vera
|
[NCBI]
|
5.05049e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
5.05049e-05
|
|
|
HSAN1
|
[NCBI]
|
4.95339e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
4.86107e-05
|
|
|
oca2 gene
|
[NCBI]
|
4.76772e-05
|
|
|
osteoporosis
|
[NCBI]
|
4.68908e-05
|
|
|
ABO
|
[NCBI]
|
4.57033e-05
|
|
|
DYX1
|
[NCBI]
|
4.53166e-05
|
|
|
DMD
|
[NCBI]
|
4.52304e-05
|
|
|
LPA
|
[NCBI]
|
4.42798e-05
|
|
|
PI
|
[NCBI]
|
4.0533e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
3.95407e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
3.89994e-05
|
|
|
POAG
|
[NCBI]
|
3.6985e-05
|
|
|
SMEI
|
[NCBI]
|
3.6985e-05
|
|
|
RTT
|
[NCBI]
|
3.44534e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
3.31533e-05
|
|
|
PNPO
|
[NCBI]
|
3.30219e-05
|
|
|
AMC
|
[NCBI]
|
3.27756e-05
|
|
|
GLS
|
[NCBI]
|
3.15211e-05
|
|
|
VWS
|
[NCBI]
|
3.13435e-05
|
|
|
CYP1A1
|
[NCBI]
|
3.07315e-05
|
|
|
ARMD1
|
[NCBI]
|
3.0344e-05
|
|
|
PLA2G1B
|
[NCBI]
|
3.03256e-05
|
|
|
P2RX4
|
[NCBI]
|
3.03256e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.73912e-05
|
|
|
GTS
|
[NCBI]
|
2.64077e-05
|
|
|
SEPT5
|
[NCBI]
|
2.59456e-05
|
|
|
SPTLC1
|
[NCBI]
|
2.59456e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
2.58478e-05
|
|
|
APOE
|
[NCBI]
|
2.51591e-05
|
|
|
FGB
|
[NCBI]
|
2.34612e-05
|
|
|
PGM3
|
[NCBI]
|
2.28221e-05
|
|
|
AMY1A
|
[NCBI]
|
2.25269e-05
|
|
|
ORM1
|
[NCBI]
|
2.2246e-05
|
|
|
WT1
|
[NCBI]
|
2.17778e-05
|
|
|
CDLS1
|
[NCBI]
|
2.15913e-05
|
|
|
SCA1
|
[NCBI]
|
2.12251e-05
|
|
|
LDLR
|
[NCBI]
|
2.06936e-05
|
|
|
ALPS
|
[NCBI]
|
2.05195e-05
|
|
|
ADHD
|
[NCBI]
|
2.05195e-05
|
|
|
DISC1
|
[NCBI]
|
2.01872e-05
|
|
|
SCZD
|
[NCBI]
|
2.01792e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.98142e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.96836e-05
|
|
|
ACH
|
[NCBI]
|
1.85911e-05
|
|
|
MLL
|
[NCBI]
|
1.72357e-05
|
|
|
PGM1
|
[NCBI]
|
1.64803e-05
|
|
|
F2
|
[NCBI]
|
1.63802e-05
|
|
|
GPT
|
[NCBI]
|
1.54656e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.4957e-05
|
|
|
SRS
|
[NCBI]
|
1.45325e-05
|
|
|
HRG
|
[NCBI]
|
1.43932e-05
|
|
|
DRPLA
|
[NCBI]
|
1.38566e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.37369e-05
|
|
|
PAEP
|
[NCBI]
|
1.32063e-05
|
|
|
MC1R
|
[NCBI]
|
1.28266e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.27687e-05
|
|
|
NRG1
|
[NCBI]
|
1.26716e-05
|
|
|
HBA2
|
[NCBI]
|
1.1696e-05
|
|
|
FGFR1
|
[NCBI]
|
1.15701e-05
|
|
|
PON1
|
[NCBI]
|
1.10567e-05
|
|
|
GC
|
[NCBI]
|
1.09819e-05
|
|
|
VEGF
|
[NCBI]
|
8.95904e-06
|
|
|
HBA1
|
[NCBI]
|
7.7079e-06
|
|
|
AD
|
[NCBI]
|
7.67723e-06
|
|
|
CP
|
[NCBI]
|
6.84991e-06
|
|
|
STAR
|
[NCBI]
|
6.78653e-06
|
|
|
VDR
|
[NCBI]
|
6.61465e-06
|
|
|
WAS
|
[NCBI]
|
5.7438e-06
|
|
|
PD
|
[NCBI]
|
4.54303e-06
|
|
|
EGF
|
[NCBI]
|
4.39539e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
3.79424e-06
|
|
|
HD
|
[NCBI]
|
3.57155e-06
|
|
|
COMT
|
[NCBI]
|
3.28855e-06
|
|
|
TTR
|
[NCBI]
|
2.83391e-06
|
|
|
TF
|
[NCBI]
|
2.68165e-06
|
|
|
HBB
|
[NCBI]
|
2.31502e-06
|
|
|
EPO
|
[NCBI]
|
1.07812e-06
|
|
|
G6PD
|
[NCBI]
|
1.06048e-06
|
|
|
ACHE
|
[NCBI]
|
5.41452e-07
|
|
|
CD
|
[NCBI]
|
2.03952e-07
|
|
|
CAT
|
[NCBI]
|
1.52918e-07
|
|
|
LPL
|
[NCBI]
|
1.06204e-07
|
|
|
CEACAM5
|
[NCBI]
|
8.93113e-08
|
|
|
BDNF
|
[NCBI]
|
8.17996e-08
|
|
|
AR
|
[NCBI]
|
1.20959e-08
|
|
|
MDD
|
[NCBI]
|
9.65638e-09
|
|